Main Management ETF Advisors LLC Has $956,000 Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Main Management ETF Advisors LLC lowered its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 8.2% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 9,968 shares of the company’s stock after selling 896 shares during the period. Main Management ETF Advisors LLC’s holdings in HealthEquity were worth $956,000 as of its most recent filing with the SEC.

Other institutional investors have also added to or reduced their stakes in the company. Wealthfront Advisers LLC bought a new stake in HealthEquity in the 4th quarter valued at $10,304,089,000. T. Rowe Price Investment Management Inc. acquired a new stake in shares of HealthEquity during the 4th quarter valued at about $78,107,000. Norges Bank acquired a new position in HealthEquity in the fourth quarter worth about $74,701,000. Raymond James Financial Inc. bought a new position in HealthEquity during the fourth quarter worth about $45,728,000. Finally, Iron Triangle Partners LP acquired a new stake in HealthEquity during the fourth quarter valued at approximately $32,202,000. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Trading Up 0.3%

HQY opened at $96.99 on Wednesday. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59. The stock has a market capitalization of $8.39 billion, a PE ratio of 88.98, a PEG ratio of 1.60 and a beta of 0.45. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a 50-day moving average price of $87.82 and a two-hundred day moving average price of $96.81.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on HQY shares. Barrington Research reissued an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a report on Friday, April 11th. Raymond James upgraded HealthEquity from an “outperform” rating to a “strong-buy” rating and dropped their price objective for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. KeyCorp cut their price objective on HealthEquity from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Wednesday, April 16th. The Goldman Sachs Group reduced their target price on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a research note on Thursday, March 27th. Finally, Wells Fargo & Company increased their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, HealthEquity has a consensus rating of “Buy” and an average target price of $111.75.

Insider Activity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction dated Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the transaction, the director now directly owns 84,969 shares in the company, valued at approximately $6,597,842.85. This represents a 6.34% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares of the company’s stock, valued at approximately $4,433,820.30. This represents a 13.55% decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.